130 related articles for article (PubMed ID: 38377738)
1. Overexpressed pigment epithelium-derived factor alleviates pulmonary hypertension in two rat models induced by monocrotaline and SU5416/hypoxia.
Miao H; Hui H; Fan W; Lin Y; Li H; Li D; Luo M; Qiu F; Jiang B; Zhang Y
Biomed Pharmacother; 2024 Mar; 172():116303. PubMed ID: 38377738
[TBL] [Abstract][Full Text] [Related]
2. TRPC4 aggravates hypoxic pulmonary hypertension by promoting pulmonary endothelial cell apoptosis.
Yang L; Peng Z; Gong F; Yan W; Shi Y; Li H; Zhou C; Yao H; Yuan M; Yu F; Feng L; Wan N; Liu G
Free Radic Biol Med; 2024 Jul; 219():141-152. PubMed ID: 38636714
[TBL] [Abstract][Full Text] [Related]
3. Dual Pigment Epithelium-derived Factor and Hepatocyte Growth Factor Overexpression: A New Therapy for Pulmonary Hypertension.
Qiu F; Jiang B; Lin Y; Li H; Li D; Luo M; Hui H; Miao H; Zhang Y
Am J Respir Cell Mol Biol; 2023 Jul; 69(1):87-98. PubMed ID: 37094101
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle endothelial delivery of PGC-1α attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling.
Cai D; Chen SY
Redox Biol; 2022 Dec; 58():102524. PubMed ID: 36334380
[TBL] [Abstract][Full Text] [Related]
5. The role of PDGF-B/TGF-β1/neprilysin network in regulating endothelial-to-mesenchymal transition in pulmonary artery remodeling.
Song S; Zhang M; Yi Z; Zhang H; Shen T; Yu X; Zhang C; Zheng X; Yu L; Ma C; Liu Y; Zhu D
Cell Signal; 2016 Oct; 28(10):1489-501. PubMed ID: 27373199
[TBL] [Abstract][Full Text] [Related]
6. PRDX6-mediated pulmonary artery endothelial cell ferroptosis contributes to monocrotaline-induced pulmonary hypertension.
Liao J; Xie SS; Deng Y; Wu DD; Meng H; Lan WF; Dai P
Microvasc Res; 2023 Mar; 146():104471. PubMed ID: 36566948
[TBL] [Abstract][Full Text] [Related]
7. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition.
Shi R; Zhu D; Wei Z; Fu N; Wang C; Liu L; Zhang H; Liang Y; Xing J; Wang X; Wang Y
Life Sci; 2018 Aug; 207():442-450. PubMed ID: 29969608
[TBL] [Abstract][Full Text] [Related]
8. Endothelial-to-mesenchymal transition in pulmonary hypertension.
Ranchoux B; Antigny F; Rucker-Martin C; Hautefort A; Péchoux C; Bogaard HJ; Dorfmüller P; Remy S; Lecerf F; Planté S; Chat S; Fadel E; Houssaini A; Anegon I; Adnot S; Simonneau G; Humbert M; Cohen-Kaminsky S; Perros F
Circulation; 2015 Mar; 131(11):1006-18. PubMed ID: 25593290
[TBL] [Abstract][Full Text] [Related]
9. A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension.
Yung LM; Nikolic I; Paskin-Flerlage SD; Pearsall RS; Kumar R; Yu PB
Am J Respir Crit Care Med; 2016 Nov; 194(9):1140-1151. PubMed ID: 27115515
[TBL] [Abstract][Full Text] [Related]
10. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
[TBL] [Abstract][Full Text] [Related]
11. Endothelial cell-related autophagic pathways in Sugen/hypoxia-exposed pulmonary arterial hypertensive rats.
Kato F; Sakao S; Takeuchi T; Suzuki T; Nishimura R; Yasuda T; Tanabe N; Tatsumi K
Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L899-L915. PubMed ID: 28798259
[TBL] [Abstract][Full Text] [Related]
12. Administration of pigment epithelium-derived factor inhibits left ventricular remodeling and improves cardiac function in rats with acute myocardial infarction.
Ueda S; Yamagishi S; Matsui T; Jinnouchi Y; Imaizumi T
Am J Pathol; 2011 Feb; 178(2):591-8. PubMed ID: 21281791
[TBL] [Abstract][Full Text] [Related]
13. Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension.
Good RB; Gilbane AJ; Trinder SL; Denton CP; Coghlan G; Abraham DJ; Holmes AM
Am J Pathol; 2015 Jul; 185(7):1850-8. PubMed ID: 25956031
[TBL] [Abstract][Full Text] [Related]
14. Pigment epithelium-derived factor attenuates myocardial fibrosis via inhibiting Endothelial-to-Mesenchymal Transition in rats with acute myocardial infarction.
Zhang H; Hui H; Li Z; Pan J; Jiang X; Wei T; Cui H; Li L; Yuan X; Sun T; Liu Z; Zhang Z; Dong H
Sci Rep; 2017 Feb; 7():41932. PubMed ID: 28167820
[TBL] [Abstract][Full Text] [Related]
15. Unilateral Lung Removal in Combination with Monocrotaline or SU5416 in Rodents: A Reliable Model to Mimic the Pathology of the Human Pulmonary Hypertension.
Katz MG; Hadas Y; Shtraizent N; Ravvin S; Madjarov JM; Eliyahu E
Methods Mol Biol; 2024; 2803():173-185. PubMed ID: 38676893
[TBL] [Abstract][Full Text] [Related]
16. NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling.
Barman SA; Chen F; Su Y; Dimitropoulou C; Wang Y; Catravas JD; Han W; Orfi L; Szantai-Kis C; Keri G; Szabadkai I; Barabutis N; Rafikova O; Rafikov R; Black SM; Jonigk D; Giannis A; Asmis R; Stepp DW; Ramesh G; Fulton DJ
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1704-15. PubMed ID: 24947524
[TBL] [Abstract][Full Text] [Related]
17. Presenilin 1 Is a Therapeutic Target in Pulmonary Hypertension and Promotes Vascular Remodeling.
Shen T; Shi J; Zhao X; Fu L; Wang N; Zheng X; Chen Y; Li M; Ma C; Liu P; Zhu D
Am J Respir Cell Mol Biol; 2024 Jun; 70(6):468-481. PubMed ID: 38381098
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of right coronary vascular dysfunction in severe pulmonary hypertensive rats using synchrotron radiation microangiography.
Inagaki T; Pearson JT; Tsuchimochi H; Schwenke DO; Saito S; Higuchi T; Masaki T; Umetani K; Shirai M; Nakaoka Y
Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H1021-H1036. PubMed ID: 33481696
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular Failure.
Park JF; Clark VR; Banerjee S; Hong J; Razee A; Williams T; Fishbein G; Saddic L; Umar S
Circ Heart Fail; 2021 Feb; 14(2):e007058. PubMed ID: 33541093
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin αvβ3/FAK/AKT Pathway Suppression.
Jia D; Zhu Q; Liu H; Zuo C; He Y; Chen G; Lu A
Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28077433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
